How much funding has Structure Therapeutics raised?

Structure Therapeutics has raised $100.0M in total funding, most recently a Series B round.

When was Structure Therapeutics founded?

Structure Therapeutics was founded in 2021.

Where is Structure Therapeutics headquartered?

Structure Therapeutics is headquartered in South San Francisco, California, United States.

What industry is Structure Therapeutics in?

Structure Therapeutics operates in Biotech, Healthcare.

How many employees does Structure Therapeutics have?

Structure Therapeutics has 51-200 employees.

Structure Therapeutics

Q: Who are Structure Therapeutics's investors?

Structure Therapeutics's investors include Eight Roads Ventures, F-Prime Capital, Qiming VP, Sequoia Capital.

IPO

Medicine is our platform. Accessibility is our cure.

Public · South San Francisco, United States · Founded 2021 · $100.0M raised

Biotech

Healthcare

Headquarters: South San Francisco, California
Employees: 51–200
Founded: 2021
Business Model: B2B
Website: structuretx.com

Total Funding: $100.0M
Last Round: $100.0M Series BOct 2021
Rounds: 1
Type: Public

About

Structure Therapeutics is a clinical-stage biopharmaceutical company leveraging structure-based drug design to develop oral small molecule therapeutics for chronic diseases including obesity. The company's platform applies proprietary GPCR structural knowledge and computational chemistry to build a broad pipeline of non-peptide medicines that are more scalable and accessible than biologics or injectable peptide therapies.

Summary

Structure Therapeutics is a Biotech company based in South San Francisco, United States, founded in 2021. It has raised $100.0M in total across 1 round, most recently a $100.0M Series B round in Oct 2021. Investors include Eight Roads Ventures, F-Prime Capital and Qiming VP.

LinkedIn X (Twitter)